ClinicalTrials.govpublic full text
A Phase I Maximum Tolerated Dose Study of CI-1012 in Late-Stage HIV+ Patients
hiv infections, hiv-1, dose-response relationship, drug, anti-hiv agents, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 876914
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.